The assessment, and glucagon-like peptide-2 modulation, of intestinal absorption and function

Seminars in Pediatric Surgery

Volumn 19, Issue 1, 2010, Pages 44-49

  Sigalet, David L ^a   Lam, Viona ^a   Boctor, Dana ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b ALBERTA CHILDREN'S HOSPITAL   (Canada)

Author keywords

3 0 Methyl glucose; Glucagon like peptide 2; Intestinal permeability; Lactulose; Mannitol; Short bowel syndrome

Indexed keywords

3 METHYLGLUCOSE; CITRULLINE; GLUCAGON LIKE PEPTIDE 2; LACTULOSE; MANNITOL; XYLOSE;

AMINO ACID BLOOD LEVEL; ANALYTIC METHOD; ARTICLE; BLOOD LEVEL; CARBOHYDRATE ABSORPTION; CELL PROLIFERATION; CLINICAL ASSESSMENT; CLINICAL TRIAL; DRUG HALF LIFE; DRUG MECHANISM; DRUG TOLERABILITY; GASTROSCHISIS; GLUCAGON BLOOD LEVEL; HUMAN; INTESTINE ABSORPTION; INTESTINE ADAPTATION; INTESTINE FUNCTION; NONHUMAN; NUTRITIONAL STATUS; PATIENT MONITORING; PRIORITY JOURNAL; SHORT BOWEL SYNDROME; VITAMIN BLOOD LEVEL;

ADAPTATION, PHYSIOLOGICAL; BIOLOGICAL MARKERS; GLUCAGON-LIKE PEPTIDE 2; HUMANS; INTESTINAL ABSORPTION; SHORT BOWEL SYNDROME;

EID: 72549107372     PISSN: 10558586     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sempedsurg.2009.11.005     Document Type: Article

References (48)

1. Martin G.R., Wallace L.E., Hartmann B., et al. Nutrient-stimulated GLP-2 release and crypt cell proliferation in experimental short bowel syndrome. Am J Physiol Gastrointest Liver Physiol 288 (2005) G431-G438
2. Wales P.W., de Silva N., Kim J.H., et al. Neonatal short bowel syndrome: a cohort study. J Pediatr Surg 40 (2005) 755-762
3. Sigalet D.L., and Martin G.R. Hormonal therapy for short bowel syndrome. J Pediatr Surg 35 (2000) 360-363
4. Sigalet D.L. Short bowel syndrome in infants and children: an overview. Semin Pediatr Surg 10 (2001) 49-55
5. Williamson R.C. Intestinal adaptation (second of two parts). Mechanisms of control. N Engl J Med 298 (1978) 1444-1450
6. Williamson R.C. Intestinal adaptation (first of two parts). Structural, functional and cytokinetic changes. N Engl J Med 298 (1978) 1393-1402
7. Spencer A.U., Kovacevich D., Kinney-Barnett M., et al. Pediatric short-bowel syndrome: the cost of comprehensive care. Am J Clin Nutr 88 (2008) 1552-1559
8. Spencer A.U., Neaga A., West B., et al. Pediatric short bowel syndrome: redefining predictors of success. Ann Surg 242 (2005) 403-409
9. Javid P.J., Collier S., Richardson D., et al. The role of enteral nutrition in the reversal of parenteral nutrition-associated liver dysfunction in infants. J Pediatr Surg 40 (2005) 1015-1018
10. Brubaker P.L., and Anini Y. Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2. Can J Physiol Pharmacol 81 (2003) 1005-1012
11. Roberge J.N., and Brubaker P.L. Secretion of proglucagon-derived peptides in response to intestinal luminal nutrients. Endocrinology 128 (1991) 3169-3174
12. Xiao Q., Boushey R.P., Drucker D.J., et al. Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans. Gastroenterology 117 (1999) 99-105
13. Jeppesen P.B., Hartmann B., Thulesen J., et al. Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon. Gut 47 (2000) 370-376
14. Sigalet D.L., Martin G., Meddings J., et al. GLP-2 levels in infants with intestinal dysfunction. Pediatr Res 56 (2004) 371-376
15. Hartmann B., Harr M.B., Jeppesen P.B., et al. In vivo and in vitro degradation of glucagon-like peptide-2 in humans. J Clin Endocrinol Metab 85 (2000) 2884-2888
16. Dube P.E., Forse C.L., Bahrami J., et al. The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice. Gastroenterology 131 (2006) 589-605
17. Martin G.R., Wallace L.E., and Sigalet D.L. Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome. Am J Physiol Gastrointest Liver Physiol 286 (2004) G964-G972
18. Sigalet D.L., Bawazir O., Martin G.R., et al. Glucagon-like peptide-2 induces a specific pattern of adaptation in remnant jejunum. Dig Dis Sci 51 (2006) 1557-1566
19. Liu X., Nelson D.W., Holst J.J., et al. Synergistic effect of supplemental enteral nutrients and exogenous glucagon-like peptide 2 on intestinal adaptation in a rat model of short bowel syndrome. Am J Clin Nutr 84 (2006) 1142-1150
20. Sangild P.T., Tappenden K.A., Malo C., et al. Glucagon-like peptide 2 stimulates intestinal nutrient absorption in parenterally fed newborn pigs. J Pediatr Gastroenterol Nutr 43 (2006) 160-167
21. Scott R.B., Kirk D., MacNaughton W.K., et al. GLP-2 augments the adaptive response to massive intestinal resection in rat. Am J Physiol 275 5 Pt. 1 (1998) G911-G921
22. Secor S.M., Whang E.E., Lane J.S., et al. Luminal and systemic signals trigger intestinal adaptation in the juvenile python. Am J Physiol Gastrointest Liver Physiol 279 (2000) G1177-G1187
23. Jeppesen P.B., Hartmann B., Thulesen J., et al. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology 120 (2001) 806-815
24. Jeppesen P.B., Sanguinetti E.L., Buchman A., et al. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut 54 (2005) 1224-1231
25. Amin H., Holst J.J., Hartmann B., et al. Functional ontogeny of the proglucagon derived peptide axis in human neonates. Pediatrics 121 (2008) e180-e186
26. Lovshin J., Yusta B., Iliopoulos I., et al. Ontogeny of the glucagon-like peptide-2 receptor axis in the developing rat intestine. Endocrinology 141 (2000) 4194-4201
27. Yoshikawa H., Miyata I., and Eto Y. Serum glucagon-like peptide-2 levels in neonates: comparison between extremely low-birthweight infants and normal-term infants. Pediatr Int 48 (2006) 464-469
28. Soon I.S., Boctor D., Holst J.J., et al. Altered development of the glucagon like peptide 2 response in infants with gastroschisis. Gastroenterology 136 4 suppl 1 (2009) A716
29. Wales P.W., de Silva N., Kim J., et al. Neonatal short bowel syndrome: population-based estimates of incidence and mortality rates. J Pediatr Surg 39 (2004) 690-695
30. DiBaise J.K., Young R.J., and Vanderhoof J.A. Intestinal rehabilitation and the short bowel syndrome. Part 2. Am J Gastroenterol 99 (2004) 1823-1832
31. Utter S., and Duggan C. Short bowel syndrome. 3rd ed. (2000), Decker, Hamilton
32. Vanderhoof J.A. Short bowel syndrome in children. Curr Opin Pediatr 7 (1995) 560-568
33. Bear M.T., and Harris A.B. Pediatric nutrition assessment: identifying children at risk. J Am Diet Assoc suppl 2 (1997) S107-S115
34. Picaud J.C., Lapillonne A., Pieltain C., et al. Software and scan acquisition technique-related discrepancies in bone mineral assessment using dual-energy X-ray absorptiometry in neonates. Acta Paediatr 91 (2002) 1189-1193
35. Rigo J. Body composition during the first year of life. Nestle Nutr Workshop Ser Pediatr Program 58 (2006) 65-76 discussion 76-8
36. Compher C., Rubesin S., Kinosian B., et al. Noninvasive measurement of transit time in short bowel syndrome. JPEN J Parenter Enteral Nutr 31 (2007) 240-245
37. Schiller L.R. Evaluation of small bowel bacterial overgrowth. Curr Gastroenterol Rep 9 (2007) 373-377
38. Cooke R.J., Paule C., and Ruckman K. Nutrient balance in the preterm infant. 3. Effect of balance duration on outcome measurements. J Pediatr Gastroenterol Nutr 8 (1989) 355-358
39. Sigalet D.L., Martin G.R., and Meddings J.B. 3-0 methylglucose uptake as a marker of nutrient absorption and bowel length in pediatric patients. JPEN J Parenter Enteral Nutr 28 (2004) 158-162
40. Rabier D., and Kamoun P. Metabolism of citrulline in man. Amino Acids 9 (1995) 229-316
41. Bailly-Botuha C., Colomb V., Thioulouse E., et al. Plasma citrulline concentration reflects enterocyte mass in children with short bowel syndrome. Pediatr Res 65 (2009) 559-563
42. Fitzgibbons S., Ching Y.A., Valim C., et al. Relationship between serum citrulline levels and progression to parenteral nutrition independence in children with short bowel syndrome. J Pediatr Surg 44 (2009) 928-932
43. Rhoads J.M., Plunkett E., Galanko J., et al. Serum citrulline levels correlate with enteral tolerance and bowel length in infants with short bowel syndrome. J Pediatr 146 (2005) 542-547
44. Luo M., Fernandez-Estivariz C., Manatunga A.K., et al. Are plasma citrulline and glutamine biomarkers of intestinal absorptive function in patients with short bowel syndrome?. JPEN J Parenter Enteral Nutr 31 (2007) 1-7
45. Sigalet D.L., Martin G.R., and Poole A. Differential sugar absorption as a marker for adaptation in short bowel syndrome. J Pediatr Surg 35 (2000) 661-664
46. Teshima C.W., and Meddings J.B. The measurement and clinical significance of intestinal permeability. Curr Gastroenterol Rep 10 (2008) 443-449
47. Fordtran J.S., Clodi P.H., Soergel K.H., et al. Sugar absorption tests, with special reference to 3-0-methyl-d-glucose and d-xylose. Ann Intern Med 57 (1962) 883-891
48. Sigalet DL, Boctor D, Robertson M, et al. Improved outcomes in paediatric intestinal failure with aggressive prevention of liver disease. Eur J Pediatr Surg 2009, Epub ahead of print.